Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Tessier

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Current Pharmaceutical Design|September 23, 2016
Engineered Autonomous Human Variable DomainsJohan Nilvebrant, Peter M Tessier, Sachdev S Sidhu
Proteins|July 7, 2011
Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regionsJoseph M Perchiacca, Moumita Bhattacharya, Peter M Tessier
Expert Opinion on Drug Delivery|January 22, 2014
Emerging methods for identifying monoclonal antibodies with low propensity to self-associate during the early discovery processPeter M Tessier, Jiemin Wu, Craig D Dickinson
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2026
Ultra-Dilute Developability Analysis of Antibody Self-Association and Non-Specific BindingNa-Young Kwon, Murat Karadag, Peter M Tessier
Trends in Biotechnology|August 13, 2013
Toward aggregation-resistant antibodies by designChristine C Lee, Joseph M Perchiacca, Peter M Tessier
Protein Science : a Publication of the Protein Society|April 13, 2004
Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatographyPeter M Tessier, Stanley I Sandler, Abraham M Lenhoff
STAR Protocols|January 31, 2022
Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesisJennifer M Zupancic, Alec A Desai, Peter M Tessier
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 16, 2024
Correction: Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious DiseasesJohn S Schardt, Neelan S Sivaneri, Peter M Tessier
Protein Engineering, Design & Selection : PEDS|January 9, 2014
Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffoldJoseph M Perchiacca, Christine C Lee, Peter M Tessier
Cell Systems|August 17, 2023
Simplifying complex antibody engineering using machine learningEmily K Makowski, Hsin-Ting Chen, Peter M Tessier
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Current Pharmaceutical Design|September 23, 2016
Engineered Autonomous Human Variable DomainsJohan Nilvebrant, Peter M Tessier, Sachdev S Sidhu
Proteins|July 7, 2011
Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regionsJoseph M Perchiacca, Moumita Bhattacharya, Peter M Tessier
Expert Opinion on Drug Delivery|January 22, 2014
Emerging methods for identifying monoclonal antibodies with low propensity to self-associate during the early discovery processPeter M Tessier, Jiemin Wu, Craig D Dickinson
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2026
Ultra-Dilute Developability Analysis of Antibody Self-Association and Non-Specific BindingNa-Young Kwon, Murat Karadag, Peter M Tessier
Trends in Biotechnology|August 13, 2013
Toward aggregation-resistant antibodies by designChristine C Lee, Joseph M Perchiacca, Peter M Tessier
Protein Science : a Publication of the Protein Society|April 13, 2004
Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatographyPeter M Tessier, Stanley I Sandler, Abraham M Lenhoff
STAR Protocols|January 31, 2022
Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesisJennifer M Zupancic, Alec A Desai, Peter M Tessier
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 16, 2024
Correction: Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious DiseasesJohn S Schardt, Neelan S Sivaneri, Peter M Tessier
Protein Engineering, Design & Selection : PEDS|January 9, 2014
Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffoldJoseph M Perchiacca, Christine C Lee, Peter M Tessier
Cell Systems|August 17, 2023
Simplifying complex antibody engineering using machine learningEmily K Makowski, Hsin-Ting Chen, Peter M Tessier
Pageof 12